PGR and neoplasm: Both, PR-A and -B as well as PR-B alone were associated with chemosensitivity to paclitaxel (P=0.007 and P=0.022, respectively), whereby tumours with relatively high levels of receptor expression appeared less sensitive to paclitaxel compared with carcinomas with low levels of the PR (Figure 3A and B).